The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

The Medical and Dental College Admission Test (MDCAT) 2024 retake in Islamabad has been postponed due to the Pakistan Tehreek ...

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

Boster Bio is also a leading manufacturer of the Western blot test, a critical service that complements its extensive IHC and ...

The Medical and Dental College Admission Test (MDCAT) 2024 retake in Islamabad has been postponed in the wake of Pakistan ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

Roche (RHHBY) announced that it has received CE Mark for its Ventana FOLR1 RxDx Assay. This is the first immunohistochemistry, or IHC, ...

NEW YORK – The European Commission (EC) on Monday granted marketing authorization to AbbVie's Elahere (mirvetuximab soravtansine) as a new therapy option for previously treated patients with folate ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii) for the treatment of adults with previously treated, unresectable or metastatic HER2-positive ...